wishdom schreef:
"The approval in Europe validates our production technology for ATryn® and our portfolio of programs, enabling us to pursue our strategy for partnering and commercializing our products," stated Geoffrey F. Cox, Ph.D., GTC's Chairman of the Board and Chief Executive Officer. "I am pleased that executives of the caliber of Ashley Lawton and Rick Finnegan have joined us as we pursue our partnering and commercialization goals."
Mooi nieuws,ben benieuwd wat het gaat kosten.
Groet.